SITC Cancer Immunotherapy CONNECT

aci17-cmyk.png

Stay Current with FDA-Approved Immunotherapy Treatments
Attend an upcoming SITC Advances in Cancer ImmunotherapyTM Program

Madison, WIS. on Sept. 6

Boston, mass. on Sept. 27




 

Submit Your Research to SITC 2018

Submit an abstract to the 33rd Annual Meeting or presentation application to the Immune Escape program by 5 p.m. PDT on Aug. 1, 2018!

Learn more

sitc_log_color.png

SITC Cancer Immunotherapy Guidelines – Cutaneous Melanoma Webinar on July 30
Join SITC experts to discuss immunotherapy treatment standards for melanoma on the recently updated clinical guidelines manuscript in a free webinar at 6 p.m. ET on July 30.

Learn More and Register

cig-big.png

JITC Earns Impact Factor of 8.374

The Journal for ImmunoTherapy of Cancer (JITC) received its first impact factor of 8.374! JITC’s impact factor ranks in the top 8 percent of all journals published in the categories of oncology and immunology.

LEARN MORE

sitc-connect-ed-cmyk_FINAL.png

Understand Cancer Immunotherapy With This
Free Online Activity

The Society for Immunotherapy of Cancer’s new online activity explains cancer immunotherapy and the immune system to patients.

Register for the online ACTIVITY

sitc_log_white.png

Learn the Value of 
SITC MEMBERSHIP!

member-ribbon-v4.pngSee members discuss the benefits of a SITC membership in this new video.

Watch The Video

SITC-blk.png

The Authoritative Cancer Immunotherapy Reference

SITC members who purchase Cancer Immunotherapy Principles and Practice receive a 20 percent discount and free shipping with a promo code.*

member-ribbon-v4.png*Available only when ordering from Demos Medical Publishing. Cannot be combined with any other offers.

Learn More

Patient

Explore resources and educational opportunities for cancer patients and those who advocate for them.

Explore

 

 

 

 

Clinician

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.

Explore

 

 

 

 

Researcher

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

Explore

 

 

 

 

Latest Discussions

  • Join SITC members, Drs. Vincenzo Bronte, Lorenzo Galluzzi and Jérôme Galon, for the Primer on Cancer Immunology and Immunotherapy at the International Conference on Immunotherapy Radiotherapy Combinations Sept. 20–22 in Paris. Attention SITC members! ...

    1 person recommends this.
  • This two day program is divided into a lectures series presented by world class scientists in the field of immuno-oncology, and a hands-on workshop laboratory to explore the optimization and troubleshooting of Opal staining, multispectral image acquisition ...

    1 person recommends this.
  • Currently scfvs, antibody-derived single chain variable fragment based CAR to target CD19 antigen is the most common CAR strategy clinically used. But based on the cited article, tumor  cells can be targeted also through use of non-antibody based approahes.This ...

Follow the SITC Twitter Feed.

 

Connect with colleagues at these Upcoming Events.

 


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

 

Learn More

 

The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More